Published on 10/31/2005 in the Prospect News Biotech Daily.
SpineMedica raises $10.6 million in series A financing
New York, Oct. 31 - SpineMedica Corp. said it raised $10.6 million in a series A financing round spread over three months.
FCA Venture Partners III, a fund managed by Nashville-based Clayton Associates, the Trelys Funds of South Carolina, and A/B Partners III LP, managed by Archbrook Capital Management of New York and Philadelphia, participated along with individual investors.
SpineMedica is an Atlanta-based medical device company developing an artificial disc implant called SaluDisc. It has licensed hydrogel Salubria for use in the spine.
| Issuer: | SpineMedica Corp.
|
| Issue: | Series A financing
|
| Amount: | $10.6 million
|
| Investors: | FCA Venture Partners III, Trelys Funds, A/B Partners III LP, individual investors
|
| Announcement date: | Oct. 31
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
